| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2008 | US20080216606 Grinding to uniform particle size; heating; pressurization;; extraction from ores, concentrates |
| 09/11/2008 | DE10340417B4 Kosmetische oder dermatologische Zubereitung mit Phytosterolen in Form einer W/O-Emulsion Cosmetic or dermatological preparation with phytosterols in the form of a W / O emulsion |
| 09/11/2008 | DE102007011702A1 Aptamer-basierte Reagenzien Aptamer-based reagents |
| 09/11/2008 | DE102007011486A1 Arzneimittel umfassend wenigstens ein Gestagen A pharmaceutical composition comprising at least one progestin |
| 09/11/2008 | DE102007011485A1 Darreichungsform mit erschwertem Missbrauch Dosage form with impeded abuse |
| 09/11/2008 | DE102006050091A1 Verfahren zur selektiven Lokalisierung von Wirkstoffen an und in Mitochondrien und entsprechende Wirkstoffe Process for the selective localization of active ingredients to and in mitochondria and corresponding active ingredients |
| 09/10/2008 | EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
| 09/10/2008 | EP1967527A1 A g protein-coupled receptor antagonist and its use for preventing and treating alzheimer s disease |
| 09/10/2008 | EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/10/2008 | EP1967522A1 New blood coagulation factor inhibitors |
| 09/10/2008 | EP1967520A2 Production of polyketides and other natural products |
| 09/10/2008 | EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 09/10/2008 | EP1967517A1 Probe for diagnosis of conformational disease |
| 09/10/2008 | EP1967516A1 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as MEK inhibitors for the treatment of hyperproliferative diseases |
| 09/10/2008 | EP1967515A1 Heterocyclic compounds |
| 09/10/2008 | EP1967513A1 Novel P2Y12 receptor antagonists |
| 09/10/2008 | EP1967221A2 Method of providing a solution for peritoneal dialysis |
| 09/10/2008 | EP1967211A1 Method of producing solid preparation disintegrating in the oral cavity |
| 09/10/2008 | EP1967203A1 Polysaccharide vaccine for staphylococcal infections |
| 09/10/2008 | EP1967193A1 Enhancement of anticancer therapy by flavonoids |
| 09/10/2008 | EP1967192A1 N-amidino pyrazinecarboxamide derivatives for use in the prophylaxis or treatment of neurodegenerative diseases |
| 09/10/2008 | EP1967191A1 Controlled/modified release oral methylphenidate formulations |
| 09/10/2008 | EP1967190A1 Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| 09/10/2008 | EP1967189A1 Methods for treating resistant or refractory tumors |
| 09/10/2008 | EP1967188A1 Pharmaceutical preparation of aqueous solution containing platinum complex |
| 09/10/2008 | EP1967187A1 Composition based on rutin and L-lysine |
| 09/10/2008 | EP1967186A1 Composition for soft contact lens and adsorption suppressing method |
| 09/10/2008 | EP1967184A1 Controlled release solid preparation |
| 09/10/2008 | EP1967183A1 Controlled release solid preparation |
| 09/10/2008 | EP1967182A1 Pharmaceutical composition comprising a salt of rosigliatazone |
| 09/10/2008 | EP1967181A1 Pharmaceutical formulation comprising a CB1-Receptor compound in a solid solution and/or solid dispersion |
| 09/10/2008 | EP1967180A1 Topical composition comprising a retinoid receptor agonist |
| 09/10/2008 | EP1967081A1 Process for the manufacture of a powder containing carotenoids |
| 09/10/2008 | EP1967067A2 Use of neuronal sodium channel antagonists together with amitraz for the control of ectoparasites in homeothermic animals |
| 09/10/2008 | EP1966378A2 Rnai-mediated inhibition of hif1a for treatment of ocular angiogenesis |
| 09/10/2008 | EP1966377A2 Modulation of eif4e-bp2 expression |
| 09/10/2008 | EP1966376A2 Prevention of retroviral infectivity through interference with ppt |
| 09/10/2008 | EP1966368A2 RNAi-MEDIATED INHIBITION OF IGFlR FOR TREATMENT OF OCULAR ANGIOGENESIS |
| 09/10/2008 | EP1966227A1 Crystalline forms of ibandronate sodium |
| 09/10/2008 | EP1966226A2 Azacytosine derivatives useful as antiviral agents |
| 09/10/2008 | EP1966222A2 Pyrazolothiazole protein kinase modulators |
| 09/10/2008 | EP1966221A1 Pyrimido- [4, 5-]-oxazines for use as dgat inhibitors |
| 09/10/2008 | EP1966218A1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 09/10/2008 | EP1966217A1 Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 09/10/2008 | EP1966215A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 09/10/2008 | EP1966214A1 Triazolopyridazines as tyrosine kinase modulators |
| 09/10/2008 | EP1966213A1 Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| 09/10/2008 | EP1966212A1 Diazepinones |
| 09/10/2008 | EP1966211A1 Triazole derivatives |
| 09/10/2008 | EP1966210A2 Sulphonamidoaniline derivatives being janus kinases inhibitors |
| 09/10/2008 | EP1966209A1 [ 1h- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders. |
| 09/10/2008 | EP1966208A1 (1-aza-bicycloý3.3.1¨n0n-4-yl)-ý5-(ih-indol-5-yl)-heteroaryl¨-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders |
| 09/10/2008 | EP1966207A2 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/10/2008 | EP1966204A1 Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 09/10/2008 | EP1966203A2 Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 09/10/2008 | EP1966202A1 Heteroaryl substituted pyrroloý2,3-b¨pyridines and pyrroloý2,3-b¨pyrimidines as janus kinase inhibitors |
| 09/10/2008 | EP1966200A1 Heterocyclic janus kinase 3 inhibitors |
| 09/10/2008 | EP1966199A1 Azaindole-2-carboxamide derivatives |
| 09/10/2008 | EP1966196A2 Pure and stable tiotropium bromide |
| 09/10/2008 | EP1966195A2 5-aryl isoxazolines for controlling invertebrate pests |
| 09/10/2008 | EP1966194A2 Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
| 09/10/2008 | EP1966193A1 New salt and polymorph of dpp-iv inhibitor |
| 09/10/2008 | EP1966192A2 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/10/2008 | EP1966191A1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists |
| 09/10/2008 | EP1966190A1 Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer |
| 09/10/2008 | EP1966189A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
| 09/10/2008 | EP1966187A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases |
| 09/10/2008 | EP1966185A2 2-AMINO-5-PIPERIDINYLIMIDAZOLONE COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION |
| 09/10/2008 | EP1966184A2 Pyridinyl-quinazoline derivatives and their medical use |
| 09/10/2008 | EP1966183A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 09/10/2008 | EP1966182A1 Inhibitors of ccr9 activity |
| 09/10/2008 | EP1966181A2 Anthranilic acid derivatives useful in treating infection with hepatitis c virus |
| 09/10/2008 | EP1966179A2 Darifenacin hydrobromide composition substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof |
| 09/10/2008 | EP1966176A1 Heterocyclic gaba-b modulators |
| 09/10/2008 | EP1966174A1 Chemical compounds |
| 09/10/2008 | EP1966172A1 Thiazoles for the treatment of proliferative disorders |
| 09/10/2008 | EP1966169A2 Compositions and methods for the inhibition of phospholipase a2 |
| 09/10/2008 | EP1966166A1 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS |
| 09/10/2008 | EP1966165A1 Pyrazine derivatives as epithelial sodium channel blocker |
| 09/10/2008 | EP1966164A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases |
| 09/10/2008 | EP1966163A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 09/10/2008 | EP1966162A2 Pyrimidine derivatives |
| 09/10/2008 | EP1966160A1 SUBSTITUTED 2-AMINOPYRIMIDINE-4-ONES, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF Aß-RELATED PATHOLOGIES |
| 09/10/2008 | EP1966158A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
| 09/10/2008 | EP1966156A2 New compounds iii |
| 09/10/2008 | EP1966155A1 Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer |
| 09/10/2008 | EP1966154A1 Imidazole derivatives for the treatment of gastrointestinal disorders |
| 09/10/2008 | EP1966152A2 Glucokinase activators |
| 09/10/2008 | EP1966151A1 Polycyclic indazole derivatives that are erk inhibitors |
| 09/10/2008 | EP1966150A1 Pyrazoles for the treatment of gerd and ibs |
| 09/10/2008 | EP1966146A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 09/10/2008 | EP1966144A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 09/10/2008 | EP1966143A2 Substituted aniline derivatives useful as histamine h3 antagonists |
| 09/10/2008 | EP1966142A2 New phenanthridine derivatives as bradykinin antagonists |
| 09/10/2008 | EP1966141A1 Six-membered heterocycles useful as serine protease inhibitors |
| 09/10/2008 | EP1966140A1 Process for synthesizing remifentanil |
| 09/10/2008 | EP1966139A1 Aspartic protease inhibitors |
| 09/10/2008 | EP1966138A2 Substituted tricyclic piperidone derivatives |
| 09/10/2008 | EP1966137A2 Piperidine derivatives |
| 09/10/2008 | EP1966134A1 Novel fused pyrrole derivatives |